Axonis Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-01. The offering totals $115.0M, of which $46.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Corey Goodman | Director | Cambridge, MA |
| Raymond J Kelleher | Director | Boston, MA |
| Jonathan J Leff | Director | Boston, MA |
| Brock Reeve | Director | Houston, TX |
| Joanna Stanicka | Director | Boston, MA |
| Shane Hegarty | Executive Officer | Boston, MA |
| Jeffrey Imbaro | Executive Officer | Boston, MA |
| Donald J Manning, M.D., Ph.D | Executive Officer | Boston, MA |
| Joanna Stanicka | Executive Officer | Boston, MA |